Journals

Conferences

Open Access Articles- Top Results for VE (nerve agent)

VE (nerve agent)

VE (nerve agent)
Skeletal formula of VE
Ball-and-stick model of VE
colspan=2 style="background:#f8eaba; border-top:2px solid transparent; border-bottom:2px solid transparent; text-align:center;" #REDIRECTmw:Help:Magic words#Other
This page is a soft redirect. Names

#REDIRECTmw:Help:Magic words#Other
This page is a soft redirect.-

IUPAC name
S-[2-(diethylamino)ethyl] O-ethyl ethylphosphonothioate
colspan=2 style="background:#f8eaba; border-top:2px solid transparent; border-bottom:2px solid transparent; text-align:center;" #REDIRECTmw:Help:Magic words#Other
This page is a soft redirect. Identifiers#REDIRECTmw:Help:Magic words#Other
This page is a soft redirect.-




ChemSpider 59011 7pxY
Jmol-3D images Image
PubChem Template:Chembox PubChem/format
colspan=2 style="background:#f8eaba; border-top:2px solid transparent; border-bottom:2px solid transparent; text-align:center;" #REDIRECTmw:Help:Magic words#Other
This page is a soft redirect. Properties

#REDIRECTmw:Help:Magic words#Other
This page is a soft redirect.-

C10H24NO2PS
Molar mass 253.34 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
 14pxY verify (what is10pxY/10pxN?)
Infobox references

VE (S-(Diethylamino)ethyl O-ethyl ethylphosphonothioate) is a "V-series" nerve agent closely related to the better-known VX nerve agent.

Like most of the agents in the V-series (with the exception of VX), VE has not been extensively studied outside of military science. Little is known about this compound other than its chemical formula.

It is commonly theorized that the so-called "second-generation" V series agents came from a cold war era Russian chemical weapons development program. They may have been developed sometime between 1950 and 1990. They have similar lethal dose levels to VX (between 10–50 mg) and have similar symptoms and method of action to other nerve agents that act on cholinesterase, and treatment remains the same, but the window for effectively treating second generation V series seizures is shorter. In addition to the standard seizures, some of the second generation V series agents are known to cause comas.

References


Template:Navbox with collapsible sections